Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) EBT Margin (2020 - 2025)

Rani Therapeutics Holdings (RANI) has 6 years of EBT Margin data on record, last reported at 7405.81% in Q1 2025.

  • For Q1 2025, EBT Margin changed N/A year-over-year to 7405.81%; the TTM value through Sep 2025 reached 3966.42%, down 820376.0%, while the annual FY2024 figure was 5504.28%, N/A changed from the prior year.
  • EBT Margin reached 7405.81% in Q1 2025 per RANI's latest filing, down from 1529.28% in the prior quarter.
  • Across five years, EBT Margin topped out at 4634.94% in Q3 2022 and bottomed at 7405.81% in Q1 2025.
  • Average EBT Margin over 5 years is 3.52%, with a median of 1084.49% recorded in 2023.
  • Peak YoY movement for EBT Margin: tumbled -324193bps in 2023, then crashed -261377bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 279.65% in 2021, then soared by 1757bps to 4634.94% in 2022, then plummeted by -77bps to 1084.49% in 2023, then crashed by -241bps to 1529.28% in 2024, then crashed by -384bps to 7405.81% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 7405.81% in Q1 2025, 1529.28% in Q4 2024, and 1084.49% in Q4 2023.